Standard

Modulation of Inflammatory Response Improves Myocardial Infarct Healing in Rats. / Sarapultsev, A. P.; Chupakhin, O. N.; Sarapultsev, P.A. et al.
In: Current Pharmaceutical Design, Vol. 20, No. 12, 04.2014, p. 1980-1986.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

BibTeX

@article{3902999c93c14a56a0ab9f62722b1e27,
title = "Modulation of Inflammatory Response Improves Myocardial Infarct Healing in Rats",
keywords = "Inflammation, L-17 compound, myocardial infarction, Tamerit, thiadiazine-2 amines, sodium nucleinate, ACUTE CORONARY SYNDROMES, NEUTROPHIL DEPLETION, INJURY, HEART, ISCHEMIA, SIZE, ANGIOGENESIS, REPERFUSION, MANAGEMENT, LEUKOCYTES",
author = "Sarapultsev, {A. P.} and Chupakhin, {O. N.} and P.A. Sarapultsev and Rantsev, {M. A.} and Medvedeva, {S. U.} and Sidorova, {L. P.} and Abidov, {M. T.} and Danilova, {I. G.}",
year = "2014",
month = apr,
language = "English",
volume = "20",
pages = "1980--1986",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers",
number = "12",

}

RIS

TY - JOUR

T1 - Modulation of Inflammatory Response Improves Myocardial Infarct Healing in Rats

AU - Sarapultsev, A. P.

AU - Chupakhin, O. N.

AU - Sarapultsev, P.A.

AU - Rantsev, M. A.

AU - Medvedeva, S. U.

AU - Sidorova, L. P.

AU - Abidov, M. T.

AU - Danilova, I. G.

PY - 2014/4

Y1 - 2014/4

KW - Inflammation

KW - L-17 compound

KW - myocardial infarction

KW - Tamerit

KW - thiadiazine-2 amines

KW - sodium nucleinate

KW - ACUTE CORONARY SYNDROMES

KW - NEUTROPHIL DEPLETION

KW - INJURY

KW - HEART

KW - ISCHEMIA

KW - SIZE

KW - ANGIOGENESIS

KW - REPERFUSION

KW - MANAGEMENT

KW - LEUKOCYTES

UR - http://www.scopus.com/inward/record.url?scp=84898661632&partnerID=8YFLogxK

UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=000334312500007

M3 - Article

VL - 20

SP - 1980

EP - 1986

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 12

ER -

ID: 405479